Legal & General Group’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,210
| Closed | -$7.96K | – | 3441 |
|
|
2024
Q1 | $7.96K | Hold |
4,210
| – | – | ﹤0.01% | 3249 |
|
|
2023
Q4 | $11.1K | Hold |
4,210
| – | – | ﹤0.01% | 3213 |
|
|
2023
Q3 | $9.68K | Hold |
4,210
| – | – | ﹤0.01% | 3274 |
|
|
2023
Q2 | $15.4K | Buy |
+4,210
| New | +$15.4K | ﹤0.01% | 3220 |
|
|
2022
Q3 | – | Sell |
-2,443
| Closed | -$6K | – | 3461 |
|
|
2022
Q2 | $6K | Sell |
2,443
-21,503
| -90% | -$52.8K | ﹤0.01% | 3429 |
|
|
2022
Q1 | $116K | Hold |
23,946
| – | – | ﹤0.01% | 2829 |
|
|
2021
Q4 | $270K | Buy |
23,946
+9,439
| +65% | +$106K | ﹤0.01% | 2596 |
|
|
2021
Q3 | $211K | Buy |
14,507
+5,381
| +59% | +$78.3K | ﹤0.01% | 2674 |
|
|
2021
Q2 | $106K | Sell |
9,126
-363
| -4% | -$4.22K | ﹤0.01% | 2712 |
|
|
2021
Q1 | $115K | Buy |
9,489
+190
| +2% | +$2.3K | ﹤0.01% | 2581 |
|
|
2020
Q4 | $116K | Hold |
9,299
| – | – | ﹤0.01% | 2545 |
|
|
2020
Q3 | $140K | Sell |
9,299
-1,143
| -11% | -$17.2K | ﹤0.01% | 2418 |
|
|
2020
Q2 | $256K | Buy |
10,442
+7,325
| +235% | +$180K | ﹤0.01% | 2309 |
|
|
2020
Q1 | $44K | Sell |
3,117
-1,148
| -27% | -$16.2K | ﹤0.01% | 2629 |
|
|
2019
Q4 | $68K | Buy |
4,265
+738
| +21% | +$11.8K | ﹤0.01% | 2710 |
|
|
2019
Q3 | $30K | Buy |
3,527
+899
| +34% | +$7.65K | ﹤0.01% | 2962 |
|
|
2019
Q2 | $20K | Hold |
2,628
| – | – | ﹤0.01% | 3190 |
|
|
2019
Q1 | $20K | Hold |
2,628
| – | – | ﹤0.01% | 3088 |
|
|
2018
Q4 | $12K | Hold |
2,628
| – | – | ﹤0.01% | 3230 |
|
|
2018
Q3 | $24K | Hold |
2,628
| – | – | ﹤0.01% | 3129 |
|
|
2018
Q2 | $31K | Buy |
2,628
+1,069
| +69% | +$12.6K | ﹤0.01% | 2999 |
|
|
2018
Q1 | $22K | Buy |
+1,559
| New | +$22K | ﹤0.01% | 3084 |
|